Solifenacin Succinate Versus Placebo in Inner City Women Ages 20-45 With Overactive Bladder

NCT00773552 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Investigator Left Institution

Conditions

Urinary Urge
Urge Incontinence
Overactive Bladder

Interventions

DRUG: solifenacin succinate
DRUG: placebo

Sponsor

Stamford Hospital